1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsImmune Deficiency Foundation (IDF) Research Grant Program is sponsored by Immune Deficiency Foundation. Grants supporting clinicians and scientists focused on primary immunodeficiency research. Uses NIH peer review model; recognizes top-ranked proposal with Michael Blaese Research Grant Award annually.
Get alerted about grants like this
Save a search for “Immune Deficiency Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Research Grant Program | Immune Deficiency Foundation Understanding primary immunodeficiency (PI) Could it be your immune system? Immunoglobulin replacement therapy Hematopoietic stem cell transplantation The immune system and genetics The more you understand about primary immunodeficiency (PI), the better you can live with the disease or support others in your life with PI.
Learn more about PI, including the various diagnoses and treatment options. Explaining your diagnosis For parents and guardians Advocating for your child Communicating with schools Managing workplace issues Living with primary immunodeficiency (PI) can be challenging, but you’re not alone—many people with PI lead full and active lives. With the right support and resources, you can, too.
Learn more about living with PI Be a hero for those with PI. Change lives by promoting primary immunodeficiency (PI) awareness and taking action in your community through advocacy, donating, volunteering, or fundraising.
Advancing research and clinical care Getting prior authorization Participating in clinical trials Advancing research and clinical care Whether you’re a clinician, researcher, or an individual with primary immunodeficiency (PI), IDF has resources to help you advance the field. Get details on surveys, grants, and clinical trials.
Learn more about research Advancing PI research and clinical care The foundation provides research grants to support clinicians and scientists focused on primary immunodeficiency (PI). IDF’s Research Grant Program supports patient-centered research focused on improving the treatment, health, disease management, or diagnosis of people with PI, as well as research that contributes to the general body of PI knowledge.
Awards range from $25,000-50,000. Exceptional proposals are considered for higher levels of support. The Michael Blaese Research Grant Award is given to the highest-scored application each cycle.
Open to U. S-based academic researchers in medicine and science conducting non-commercial research. Investigators (MD, DO, PhD, RN) with an interest in, or currently pursuing, a career in primary immunodeficiency and research are particularly encouraged to apply.
Note that medical, graduate, or other professional school students can apply as long as they have the support of an appropriate mentor; the application should be submitted in the mentor's name with the student listed as a team member. Currently unavailable for individuals employed by federal government agencies or departments. Thank you for your interest in our research grant program.
IDF’s Research Committee, made up of recognized immunologists and past grant awardees, reviews and scores research proposals through a peer review process based on the system used by the National Institutes of Health (NIH). The committee recommends funding for the proposals with the highest scores, ensuring an unbiased and independent selection process based on scientific merit. Applications for 2025 are now closed.
The application deadline of June 30, 2025, has passed, and we are no longer accepting submissions for this year's research grant program. Stay tuned for 2026. Contact us with any questions or concerns about IDF's Research Grant Program.
2025’s four Research Grant Program awardees will use their funding to better understand some of the rarest primary immunodeficiencies (PIs) and develop diagnostics and treatments. Grantees are pictured from left to right, Drs. Eric Allenspach, Caroline Kuo, Ashley Lee, and Patrick O'Connell.
Starting in 2022, the top-ranked grant in each cycle has been awarded the Michael Blaese Research Grant Award, named in honor of the foundation's long-time medical advisor and noted PI researcher, Dr. Michael Blaese . Blaese awardee : Dr. Eric Allenspach, Seattle Children’s Hospital.
Dr. Caroline Kuo, University of California, Los Angeles; Dr. Ashley Lee, Columbia University Irving Medical Center; Dr. Patrick O’Connell, Mount Sinai Kravis Children’s Hospital. Read about the 2025 winning grants. Blaese awardee : Dr. Emily Harris, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
Dr. David Nguyen, University of California, San Francisco; Dr. Alexandra Martinson, Children's National Hospital; Dr. Lauren Meyer, Seattle Children’s Hospital. Read about the 2024 winning grants . Blaese awardee : Dr. Donald Kohn, University of California, Los Angeles.
Dr. Benjamin Solomon, Stanford University; Dr. Xiao Peng, Johns Hopkins University; Dr. Brynn O’Laughlin, Children’s National Hospital; Dr. Junghee Jenny Shin, Yale University. Read about the 2023 winning grants . Blaese awardee : Dr. Joud Hajjar, Baylor College of Medicine.
Dr. Brenna LaBere, Boston Children’s Hospital; Dr. Beth Thielen, University of Minnesota; Dr. Artemio Jongco, Feinstein Institutes of Medical Research. Read about the 2022 winning grants.
Dr. Alice Chau, Seattle Children’s Institute; Dr. Pietro Genovese, Dana Farber Cancer Institute; Dr. Sarah Henrickson, Children's Hospital of Philadelphia; Dr. Michelle Hermiston, University of California San Francisco; Dr. Paul Maglione, Boston University School of Medicine; Dr. Bethany Percha, Icahn School of Medicine at Mount Sinai; Dr. Qian Zhang, The Rockefeller University. View 2020 awarded grants .
Dr. Shanmuganathan Chandrakasan, Emory University; Dr. Stacey Lynn Clardy, University of Utah; Dr. Rui Yang, The Rockefeller University; Dr. Carolyn Baloh, Duke University. View 2018 and 2019 awarded grants. Dr. Lori Broderick, University of California, San Diego; Dr. Megan Cooper, St.
Louis Children’s Hospital Foundation; Dr. Attila Kumanovics, University of Utah; Dr. Carrie L. Lucas, Yale University. View 2018 and 2019 awarded grants.
Dr. Sara Barmettler, Massachusetts General Hospital; Dr. Nilesh Chitnis, Children's Hospital of Philadelphia; Dr. Joud Hajjar, Baylor School of Medicine; Dr. Artemio Jongco, Feinstein Institute for Medical Research; Dr. Sergio Rosenzweig, National Institutes of Health. Dr. Sonia Sharma, La Jolla Institute for Allergy & Immunology. View 2016 and 2017 awarded grants.
In 2022, IDF sponsored a White Paper Challenge to seek out new ideas and address relevant topics in the PI community. We invited submissions from all individuals, institutions, schools, and researchers with exciting ideas about expanding awareness in communities of color, improving access to clinical trials, and shortening the time from diagnosis to treatment.
Discover more research opportunities The IDF Survey Research Center provides current information on PI through the analysis of patient and caregiver survey responses. Provide your patients with information on participating in clinical trials for PI. Receive news and helpful resources to your cell phone or inbox.
You can change or cancel your subscription at any time. Immune Deficiency Foundation 7550 Teague Road, Suite 220 The Immune Deficiency Foundation improves the diagnosis, treatment, and quality of life for every person affected by primary immunodeficiency. We foster a community that is connected, engaged, and empowered through advocacy, education, and research.
Combined Charity Campaign | CFC# 66309 © 2026 Immune Deficiency Foundation | Immune Deficiency Foundation is a 501(c)(3) organization (EIN: 52-1214782 )
Based on current listing details, eligibility includes: Universities and research institutions; clinicians and scientists; researchers studying primary immunodeficiencies. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $25,000-$75,000 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is June 30, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.